Federal Register Notice: FDA is inviting public comment on information collection requirements imposed on firms that intend to export to countries that require an export certificate as a condition of entry for FDA-regulated products, pharmaceuticals, biologics, and devices as indicated in the FD&C Act as amended. Comments should be submitted by 1/13/15. To view this notice, click here.
